Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pre-Employment Drug Testing
- Pre employment drug testing is extremely important for any organization. Verification of employee's background is always considered as essential of assurance in the hiring process. Employee drug testing programs protects the health and safety of all employees. This testing proves to be an efficient method of managing drug abuse. It...
- White papers 2008-01-11
Additional Resources
- Olympians may face more drug testing
- COPENHAGEN, Denmark -- NBA players on Olympic teams will face out- of-competition, random drug tests for the 2004 Athens Games starting July 1 as part of a global program that is expected to be approved today. Under the system, which applies to athletes in all Olympic sports,...
- Research articles 2003-03-05
- USADA gives US Olympians pre-Games review of test rules
- COLORADO SPRINGS, Colorado AFP — US Anti-Doping Agency USADA officials are increasing educational efforts for US Olympians ahead of the Beijing Games by advising athletes about new drug testing rules. US delegation members will be subject to International Olympic Committee IOC rules from Sunday's opening of the Olympic Village...
- Research articles 2008-07-25
- Inspire Announces Plans to Begin Phase 2 Testing of Intranasal Epinastine for Seasonal Allergic Rhinitis; Pre-Investigational New Drug Meeting Completed With FDA
- DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today plans to file an Investigational New Drug IND application and begin Phase 2 clinical testing of intranasal epinastine for the treatment of seasonal allergic rhinitis, following the recent completion of a pre-IND meeting with the U.S. Food and Drug Administration...
- Research articles 2006-05-31
- Merck KGaA drops Parkinson's drug after clinical trials fail
- DARMSTADT, Germany AFP — Merck KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson's disease, after Phase III clinical trials failed. The Phase III trials, the final set of testing...
- Research articles 2006-06-23
- Dendreon: Pro-Provenge Activists Heap Abuse on Cancer Drug’s Critics
- Dendreon: Pro-Provenge Activists Heap Abuse on Cancer Drug’s CriticsRE: Dendreon: Pro-Provenge Activists Heap Abuse on Cancer Drug’s CriticsThe final result has to show a 22% reduction in deaths. The interim showed a 20% reduction, closely matching previous trials. The final result of previous trials showed a 33% reduction...
- Discussion threads 2008-10-07
- Cytyc Receives Expanded Labeling to Facilitate Molecular Testing with the ThinPrep® Pap Test
- MARLBOROUGH, Mass. -- Cytyc Corporation (Nasdaq:CYTC) today announced that the U.S. Food and Drug Administration FDA has approved a Pre-Market Approval Supplement for the ThinPrepR Pap Test related to the testing of ThinPrep Pap Test samples by molecular diagnostic methods. The approval allows the removal of up to 4 ml...
- Research articles 2005-09-29
- OLY: Rogge vows to clean Olympic village of drug cheats
- 00-00-0000 OLY: Rogge vows to clean Olympic village of drug cheats IOC president JACQUES ROGGE has vowed to clean the athletes village of drug cheats before the opening ceremony of the Winter Games on Saturday afternoon, AUstralian time. ...
- Research articles 2002-02-08
- U.S. Food and Drug Administration Clears Personal Lubricant for Marketing; New Product from Instead, Inc. Shows Promise for Women
- LA JOLLA, Calif. -- The U.S. Food and Drug Administration FDA has granted Instead, Inc. clearance to market its personal lubricant product, AmphoraTM. In addition to its lubricating properties, Amphora has been shown, in early clinical and pre-clinical tests, to immobilize sperm for up to eight hours when applied vaginally...
- Research articles 2004-09-09
- Human BioSystems Scheduled to Meet with the FDA to Discuss Platelet Human Infusion Testing
- PALO ALTO, Calif. -- Human BioSystems ("HBS" or "Company") (OTCBB:HBSC) announced today that a pre-IND Investigational New Drug application meeting with the FDA Food and Drug Administration has been scheduled for early October to discuss HBS's plan to conduct human infusion tests using the Company's patented platelet preservation system.
- Research articles 2006-09-12
- Mexico bans drug offenders
- MEXICO CITY AFP — Mexico defenders Salvador Carmona and Aaron Galindo have been banned for a year after testing positive for a derivative of nandrolone, a banned anabolic steroid. The pair were expelled from last month's Confederations Cup in Germany when the doping results, from pre-tournament testing, came to...
- Research articles 2005-07-05
- Meijer Expands Food and Drug Initiatives in Smaller Format
- In its 75th anniversary year, Meijer is going back to its roots, developing a grocery-oriented format it will test in Niles, Ill. While half the size of a typical Meijer supercenter, the new format won’t be tiny, coming in at 102,000 square feet. It is scheduled to...
- Blog posts 2009-06-30
- Home Access enters race to market new HIV home test device; New contender files for FDA pre-market approval
- ROLLING MEADOWS, Ill.--HealthWire--June 1, 1995--Home Access Health Corporation, a Chicago-area developmental stage company specializing in health care communications and technology, announced today that it has filed for approval of its HIV education, counseling and testing service with the U.S. Food and Drug Administration.
- Research articles 1995-06-01
- NASA investigation can't find evidence of astronauts pre-launch
- WASHINGTON -- An internal NASA health and safety report recommends the space agency explore the idea of drug and alcohol testing for astronauts and other employees. While the review released Wednesday found no evidence that astronauts were drunk or had been drinking heavily before any space launch --...
- Research articles 2007-08-29
- Duke University
- * A plastic material developed by researchers at Duke University in Durham has qualified for an evaluation by the U.S. Food and Drug Administration as a biocompatible material. Duramer, the name given to the material developed by Stephen Kovacs and his associates in Duke's thoracic surgery research laboratory, passed 18...
- Research articles 2001-02-01
- Need to know: Bingo tax burden ... Altria profits rise ... Boots health website ...
- View video and Need to Know interactive heatmap Economics Interest rates: Bank of England policymakers voted unanimously this month to keep interest rates at 0.5 per cent and to keep the size of its asset purchase programme unchanged at ÂŁ175 billion, the minutes from the meeting of the Bank's Monetary...
- News items 2009-10-21
- Home Access Health's At-Home Hepatitis C Test to Receive Expedited and Streamlined Review From FDA
- HOFFMAN ESTATES, Ill.--BW HealthWire--Feb. 19, 1999--The United States Food and Drug Administration FDA has informed Home Access Health Corporation that its pre-market approval application PMA for an at-home telemedicine Hepatitis C counseling and testing servi ice will received expedited review and streamlined processing from the agency.
- Research articles 1999-02-19
- New nationwide HIV home test services receive FDA clearance; Home Access Express to offer results in three business days
- HOFFMAN ESTATES, Ill.--HealthWire--July 24, 1996--Home Access Health Corporation announced today that it has received clearance from the U.S. Food and Drug Administration FDA to market Home Access ExpressTM and Home AccessTM, the first HIV-1 testing and counseling systems to allow people nationwide to anonymously collect a blood sample, access professional...
- Research articles 1996-07-24
- Canadian star Theodore slapped with two-year ban for doping offence
- OTTAWA, Canada AFP — Canadian hockey star Jose Theodore has been slapped with a two-year suspension from international competition after testing positive for a banned substance. The 29-year-old Colorado Avalanche goaltender failed a drug test during a random pre-Olympic screening on December 9 for a substance that can be...
- Research articles 2006-03-18
- Double Digit Moves and Heavy Trading Following News.
- VANCOUVER, BRITISH COLUMBIA, Apr 3, 2002 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was Cygnus, Inc. (NASDAQ: CYGN) announcing Tuesday that it has received supplemental pre-market approval PMA from the...
- Research articles 2002-04-03
- << Previous
- page 1 of 1
- Next >>
